When did Denali Therapeutics Inc. report Q4 2024 earnings?

Denali Therapeutics Inc. (DNLI) reported Q4 2024 earnings on February 27, 2025 before market open.

What were Denali Therapeutics Inc.'s Q4 2024 revenue and EPS?

Denali Therapeutics Inc. reported revenue of - and eps of $-0.67 for Q4 2024.

Did Denali Therapeutics Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.75 by $0.08.

Where can I find Denali Therapeutics Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001714899-25-000066) directly on SEC EDGAR. The filing index links above go to sec.gov.

Denali Therapeutics Inc. DNLI Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue-

EPS-$0.67Beat by $0.08

EPS estimate-$0.75

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$2.2M

EPS estimate-$0.54

Financials

Q4 2024

Income statement

See full

Revenue-—

Operating income-$129.8M+2.1%

Net income-$114.8M+4.0%

EPS (diluted)-$0.68+21.8%

Balance sheet

See full

Cash & equivalents$176.5M+37.2%

Total debt$54.3M+4.0%

Total equity$1.2B+19.3%

Total assets$1.4B+19.1%

Cash flow

See full

Operating cash flow-$83.7M+15.1%

CapEx$5.1M+128%

Free cash flow-$88.8M+12.0%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.93B-1.1%

Enterprise value$2.81B-2.7%

Returns & leverage

See full

Return on equity-37.4%-93.2pp

Debt / equity0×0.0×

Current ratio8.5×-5.2×

Segments

By segment

See full

Therapeutics Segment--100%

Versus estimates

Diluted EPS

Q1 2026-$0.69Beat by $0.04 Q4 2025-$0.73Beat by $0.02 Q3 2025-$0.74Beat by $0.02 Q2 2025-$0.72Beat by $0.02 Q1 2025-$0.78Miss by $0.07

Q4 2024-$0.67Beat by $0.08

Ask the moment Denali Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Denali Therapeutics Inc. report Q4 2024 earnings?: Denali Therapeutics Inc. (DNLI) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Denali Therapeutics Inc.'s Q4 2024 revenue and EPS?: Denali Therapeutics Inc. reported revenue of - and eps of $-0.67 for Q4 2024.
Did Denali Therapeutics Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.75 by $0.08.
Where can I find Denali Therapeutics Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001714899-25-000066) directly on SEC EDGAR. The filing index links above go to sec.gov.